Different effects of clazosentan on consequences of subarachnoid hemorrhage in rats

Brain Research

Volumn 1392, Issue , 2011, Pages 132-139

  Chen, Gang ^a   Tariq, Asma ^a   Ai, Jinglu ^a   Sabri, Mohammed ^a,b   Jeon, Hyo Jin ^a,b   Tang, Elaine J Y ^a   Lakovic, Katarina ^a,b   Wan, Hoyee ^a   Macdonald, R Loch ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Clazosentan; Endothelin; Long term potentiation; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

CLAZOSENTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; LONG TERM POTENTIATION; MALE; MICROTHROMBUS; MORTALITY; NERVE CELL INHIBITION; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE;

ANALYSIS OF VARIANCE; ANIMALS; CASPASE 3; CHI-SQUARE DISTRIBUTION; DIOXANES; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; FIBRINOGEN; HIPPOCAMPUS; IN SITU NICK-END LABELING; LONG-TERM POTENTIATION; MALE; ORGANIC CHEMICALS; PHOSPHOPYRUVATE HYDRATASE; PYRIDINES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; SULFONAMIDES; TETRAZOLES; VASOSPASM, INTRACRANIAL;

RATTUS;

EID: 79955935925     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.03.068     Document Type: Article

References (19)

1. Cahill, J., Zhang, J.H., 2009. Subarachnoid hemorrhage: is it time for a new direction? Stroke 40, S86-S87.
2. DorhoutMees, S.M., Rinkel, G.J., Feigin, V.L., Algra, A., van den Bergh, W.M., Vermeulen, M., van, G.J., 2007. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst. Rev. CD000277.
3. Dreier, J.P., Major, S., Manning, A., Woitzik, J., Drenckhahn, C., Steinbrink, J., Tolias, C., Oliveira-Ferreira, A.I., Fabricius, M., Hartings, J.A., Vajkoczy, P., Lauritzen, M., Dirnagl, U., Bohner, G., Strong, A.J., 2009. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 132, 1866-1881.
4. Dreier, J.P., Windmuller, O., Petzold, G., Lindauer, U., Einhaupl, K.M., Dirnagl, U., 2002. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats. Neurosurgery 51, 1457-1465.
5. Haley Jr., E.C., Kassell, N.F., Torner, J.C., 1993. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. JNS 78, 537-547. (Pubitemid 23099461)
6. Hansen-Schwartz, J., Vajkoczy, P., Macdonald, R.L., Pluta, R.M., Zhang, J.H., 2007. Cerebral vasospasm: looking beyond vasoconstriction. Trends Pharmacol. Sci. 28, 252-256.
7. Jeon, H., Ai, J., Sabri, M., Tariq, A., Macdonald, R.L., 2010. Learning deficits after experimental subarachnoid hemorrhage in rats. Neuroscience 169, 1805-1814.
8. Macdonald, R.L., Kassell, N.F., Mayer, S., Ruefenacht, D., Schmiedek, P., Weidauer, S., Frey, A., Roux, S., Pasqualin, A., 2008. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39, 3015-3021.
9. Macdonald, R.L., Pluta, R.M., Zhang, J.H., 2007. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat. Clin. Pract. Neurol. 3, 256-263.
10. Macdonald, R.L., Weir, B., 2001. Cerebral Vasospasm. Academic Press, San Diego.
11. Paxinos, G., Franklin, K.B.J., 2004. The Mouse Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, San Diego.
12. Pluta, R.M., Hansen-Schwartz, J., Dreier, J., Vajkoczy, P., Macdonald, R.L., Nishizawa, S., Kasuya, H., Wellman, G., Keller, E., Zauner, A., Dorsch, N., Clark, J., Ono, S., Kiris, T., Leroux, P., Zhang, J.H., 2009. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol. Res. 31, 151-158.
13. Prunell, G.F., Mathiesen, T., Svendgaard, N.A., 2002. A new experimental model in rats for study of the pathophysiology of subarachnoid hemorrhage. Neuroreport 13, 2553-2556. (Pubitemid 36143561)
14. Roux, S., Breu, V., Giller, T., Neidhart, W., Ramuz, H., Coassolo, P., Clozel, J.P., Clozel, M., 1997. Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm. J. Pharmacol. Exp. Ther. 283, 1110-1118.
15. Schubert, G.A., Schilling, L., Thome, C., 2008. Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats. JNS 109, 1134-1140.
16. Sterio, D.C., 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J.Microsc. 134 (Pt 2), 127-136. (Pubitemid 14121386)
17. Tariq, A., Ai, J., Chen, G., Sabri, M., Jeon, H., Shang, X., Macdonald, R.L., 2010. Loss of long-term potentiation in the hippocampus after experimental subarachnoid hemorrhage in rats. Neuroscience 165, 418-426.
18. Vergouwen, M.D., Vermeulen, M., Coert, B.A., Stroes, E.S., Roos, Y.B., 2008. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J. Cereb. Blood Flow Metab. 28, 1761-1770.
19. Wang, Z., Chen, G., Zhu, W.W., Bian, J.Y., Shen, X.O., Zhou, D., 2010. Influence of simvastatin on microthrombosis in the brain after subarachnoid hemorrhage in rats: a preliminary study. Ann. Clin. Lab. Sci. 40, 32-42.